Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ardelyx Inc. | 2 | 1 | 1 | 1 | €5.70 | €11.00 | 92.982% |
| arGEN X BV | 1 | 0 | 0 | 0 | €425.60 | €470.00 | 10.432% |
| Arrowhead Pharmaceuticals Inc. | 32 | 2 | 16 | 0 | €25.51 | €42.87 | 68.065% |
| Ascendis Ph.sp.adr 1 Dk 1 | 9 | 0 | 8 | 0 | €125.00 | €150.00 | 20.000% |
| Astellas Pharma Inc. | 2 | 0 | 0 | 0 | €9.72 | €16.00 | 64.643% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €145.00 | €165.00 | 13.793% |
| Aurinia Pharmaceuticals Inc. | 7 | 5 | 7 | 4 | €5.23 | €7.00 | 33.946% |
| Avadel Pharmaceuticals plc ADR | 15 | 0 | 14 | 0 | €15.10 | €18.00 | 19.205% |
| Avid Bioservices Inc | 12 | 1 | 10 | 1 | €7.60 | €9.10 | 19.737% |
| Axsome Therapeutics Inc | 15 | 0 | 14 | 0 | €75.30 | €90.00 | 19.522% |
| Bavarian Nordic A/S | 19 | 0 | 19 | 0 | €24.48 | €30.00 | 22.549% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €7.00 | €11.05 | 57.907% |
| Biogen Inc. | 73 | 1 | 23 | 0 | €206.80 | €282.11 | 36.418% |
| BioInvent International AB | 19 | 0 | 19 | 0 | €3.17 | €4.50 | 42.180% |
| BioMarin Pharmaceutical Inc. | 26 | 0 | 9 | 0 | €78.78 | €98.62 | 25.181% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €106.30 | - | - |
| Brainstorm Cell | 2 | 0 | 1 | 0 | €0.37 | €1.84 | 403.288% |
| Catalent Inc. | 15 | 0 | 14 | 0 | €53.10 | €60.00 | 12.994% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 0 | 0 | €15.42 | €24.13 | 56.506% |
| Celldex Therapeutics | 16 | 1 | 3 | 0 | €36.40 | €61.99 | 70.298% |
| Cellectis Nom. | 19 | 0 | 19 | 0 | €1.85 | €2.50 | 34.844% |
| CEL-SCI Corp. | 5 | 5 | 5 | 4 | €1.36 | €1.50 | 10.132% |
| Celsion Corp. | 1 | 1 | 1 | 0 | €1.27 | €2.00 | 57.480% |
| Cerenis Therapeutics Holding S.A. | 1 | 0 | 0 | 0 | €1.16 | €1.60 | 37.931% |
| Charles River Labs Intl | 12 | 0 | 1 | 0 | €208.60 | €248.57 | 19.161% |